These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 28644440)
21. Androgen receptor regulates ASS1P3/miR-34a-5p/ASS1 signaling to promote renal cell carcinoma cell growth. Wang K; Sun Y; Guo C; Liu T; Fei X; Chang C Cell Death Dis; 2019 Apr; 10(5):339. PubMed ID: 31000693 [TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA HOTTIP promotes renal cell carcinoma progression through the regulation of the miR-615/IGF-2 pathway. Wang Q; Wu G; Zhang Z; Tang Q; Zheng W; Chen X; Chen F; Li Q; Che X Int J Oncol; 2018 Nov; 53(5):2278-2288. PubMed ID: 30226576 [TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling. Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173 [TBL] [Abstract][Full Text] [Related]
24. A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma. Zhai W; Zhu R; Ma J; Gong D; Zhang H; Zhang J; Chen Y; Huang Y; Zheng J; Xue W Mol Cancer; 2019 Apr; 18(1):81. PubMed ID: 30953521 [TBL] [Abstract][Full Text] [Related]
25. miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B. Wang C; Wu C; Yang Q; Ding M; Zhong J; Zhang CY; Ge J; Wang J; Zhang C Oncotarget; 2016 Nov; 7(45):73888-73902. PubMed ID: 27729617 [TBL] [Abstract][Full Text] [Related]
26. CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway. Chen Q; Liu T; Bao Y; Zhao T; Wang J; Wang H; Wang A; Gan X; Wu Z; Wang L Cancer Lett; 2020 Jan; 469():68-77. PubMed ID: 31629934 [TBL] [Abstract][Full Text] [Related]
27. miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8. Liu F; Chen N; Xiao R; Wang W; Pan Z Biochem Biophys Res Commun; 2016 Nov; 480(1):87-93. PubMed ID: 27717821 [TBL] [Abstract][Full Text] [Related]
28. Biological function and mechanism of MALAT-1 in renal cell carcinoma proliferation and apoptosis: role of the MALAT-1-Livin protein interaction. Chen S; Ma P; Zhao Y; Li B; Jiang S; Xiong H; Wang Z; Wang H; Jin X; Liu C J Physiol Sci; 2017 Sep; 67(5):577-585. PubMed ID: 27655020 [TBL] [Abstract][Full Text] [Related]
29. Kidney cancer: AR promotes RCC via lncRNA interaction. Fenner A Nat Rev Urol; 2016 May; 13(5):242. PubMed ID: 27041208 [No Abstract] [Full Text] [Related]
30. LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG. Pu Y; Dong Z; Xia Y; Zhang M; Song J; Han J; Liu H Biomed Pharmacother; 2019 Oct; 118():109382. PubMed ID: 31545257 [TBL] [Abstract][Full Text] [Related]
31. LncRNA SNHG1 regulates immune escape of renal cell carcinoma by targeting miR-129-3p to activate STAT3 and PD-L1. Tian P; Wei JX; Li J; Ren JK; Yang JJ Cell Biol Int; 2021 Jul; 45(7):1546-1560. PubMed ID: 33739543 [TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA HOTAIR promotes renal cell carcinoma malignancy through alpha-2, 8-sialyltransferase 4 by sponging microRNA-124. Pan Y; Wu Y; Hu J; Shan Y; Ma J; Ma H; Qi X; Jia L Cell Prolif; 2018 Dec; 51(6):e12507. PubMed ID: 30105850 [TBL] [Abstract][Full Text] [Related]
33. Depletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathway. Zhang H; Sheng L; Tao J; Chen R; Li Y; Sun Z; Qian W Int J Oncol; 2016 Dec; 49(6):2498-2506. PubMed ID: 27779645 [TBL] [Abstract][Full Text] [Related]
34. LncRNA PCGEM1 promotes renal carcinoma progression by targeting miR-433-3p to regulate FGF2 expression. Cai X; Zhang X; Mo L; Zhu J; Yu H Cancer Biomark; 2020; 27(4):493-504. PubMed ID: 31958075 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma. Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776 [TBL] [Abstract][Full Text] [Related]
36. Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression. Shi H; Sun Y; He M; Yang X; Hamada M; Fukunaga T; Zhang X; Chang C Oncogene; 2020 Jan; 39(3):530-545. PubMed ID: 31501521 [TBL] [Abstract][Full Text] [Related]
37. LncRNA SNHG17 promotes tumor progression and predicts poor survival in human renal cell carcinoma via sponging miR-328-3p. Wu J; Dong G; Liu T; Zhang S; Sun L; Liang W Aging (Albany NY); 2021 Sep; 13(17):21232-21250. PubMed ID: 34497156 [TBL] [Abstract][Full Text] [Related]
38. DNA-methylation-mediated repression of miR-766-3p promotes cell proliferation via targeting SF2 expression in renal cell carcinoma. Chen C; Xue S; Zhang J; Chen W; Gong D; Zheng J; Ma J; Xue W; Chen Y; Zhai W; Zheng J Int J Cancer; 2017 Nov; 141(9):1867-1878. PubMed ID: 28657135 [TBL] [Abstract][Full Text] [Related]
39. Sunitinib increases the cancer stem cells and vasculogenic mimicry formation via modulating the lncRNA-ECVSR/ERβ/Hif2-α signaling. He M; Yang H; Shi H; Hu Y; Chang C; Liu S; Yeh S Cancer Lett; 2022 Jan; 524():15-28. PubMed ID: 34461182 [TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA XIST regulates miR-106b-5p/P21 axis to suppress tumor progression in renal cell carcinoma. Sun K; Jia Z; Duan R; Yan Z; Jin Z; Yan L; Li Q; Yang J Biochem Biophys Res Commun; 2019 Mar; 510(3):416-420. PubMed ID: 30717973 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]